Taken together, our findings highlight the emerging role of heparanase in modulating pro-tumorous effect of hyperinsulinemic state on breast tumorigenesis and imply that heparanase-targeting therapeutic approaches could be particularly beneficial in breast carcinoma patients suffering from metabolic disorders. Here, HPSE is linked to breast carcinoma.